Microglial activation after peripheral nerve injury is generally detected by immunocytochemical staining using the OX42 antibody, directed against a complement receptor 3 antigen (CD11b/c) or antibody against ionized calcium binding adapter molecule 1 (Iba1) [54, 55]. This evidence concerns the gene AIF1 and peripheral nerve injury.